WallStreetZenWallStreetZen
Analyst Ranking
Bottom 7%
#4175 out of 4481 analysts
Average Return
-11.55%
Win Rate
50%9 out of 18
Risk vs Reward
Poor
Good

John Sourbeer's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Akoya Biosciences IncAKYA
+63.35%$3.47$5.66
2023-10-11 -
2024-02-28
Strong Buy
Catalent IncCTLT
+33.32%$43.85$58.46
2023-06-12 -
2024-02-06
Strong Buy
Catalent IncCTLT
+19.35%$48.98$58.46
2023-08-29 -
2024-02-06
Strong Buy
Icon PLCICLR
+18.89%$215.91$256.69
2022-09-06 -
2023-09-06
Strong Buy
Abbott LaboratoriesABT
+18.40%$99.25$117.51
2020-07-16 -
2021-07-16
Strong Buy

John Sourbeer Analyst Color

Get additional color on John Sourbeer's coverage of popular stocks

John Sourbeer's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
West Pharmaceutical Services IncWST
2Hold$375.00+4.95%Maintains
13 days ago
Pacific Biosciences Of California IncPACB
2Strong Buy$12.00+115.44%Maintains
13 days ago
Bruker CorpBRKR
2Strong Buy$94.00+8.70%Maintains
14 days ago
Medpace Holdings IncMEDP
3Strong Buy$452.00+12.12%Upgrades
15 days ago
Catalent IncCTLT
4Hold$63.50+9.60%Downgrades
24 days ago
Qiagen NvQGEN
3Hold$43.26+0.14%Maintains
4 months ago
Nanostring Technologies IncNSTGQ
2Strong Buy$2.50+2,280.95%Maintains
5 months ago
Akoya Biosciences IncAKYA
1Strong Buy$7.00+23.67%Maintains
5 months ago
Cryoport IncCYRX
3Hold$17.00+2.91%Downgrades
7 months ago
Illumina IncILMN
1Hold$240.00N/AMaintains
a year ago
10x Genomics IncTXG
1Hold$50.00N/AInitiates Coverage On
a year ago
Syneos Health IncSYNH
1Hold$68.00N/AInitiates Coverage On
a year ago
Icon PLCICLR
1Strong Buy$270.00N/AInitiates Coverage On
a year ago
Singular Genomics Systems IncOMIC
1Hold$4.50N/ADowngrades
2 years ago
Abbott LaboratoriesABT
2Strong Buy$128.00N/AMaintains
2 years ago
Zymergen IncZY
2Hold$4.00N/AMaintains
2 years ago
Stevanato Group SpaSTVN
1Hold$22.00N/AInitiates Coverage On
3 years ago
Ortho Clinical Diagnostics Holdings PLCOCDX
1Strong Buy$23.00N/AInitiates Coverage On
3 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.